Company news

ICON plc news in 2025

ICON plc's news releases, calls and decks from 2025, newest first.

View company

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

December 8, 2025

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

December 1, 2025

ICON plc to Present at the Jefferies London Healthcare Conference

November 11, 2025

ICON Reports Third Quarter 2025 Results

October 21, 2025

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

September 23, 2025

ICON Announces CEO Transition

September 3, 2025

ICON plc to Participate at Upcoming Investor Conferences

September 1, 2025

ICON Reports Second Quarter 2025 Results

July 22, 2025

ICON Announces Results of Annual General Meeting

July 22, 2025

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

July 15, 2025

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

July 6, 2025

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

June 22, 2025

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 26, 2025

ICON releases its ICON Cares 2024 Report

May 18, 2025

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

May 6, 2025

ICON Reports First Quarter 2025 Results

April 29, 2025

ICON plc Schedules First Quarter 2025 Earnings Conference Call

March 30, 2025

ICON plc to Present at Upcoming Investor Conferences

March 4, 2025

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

March 3, 2025

ICON Reports Fourth Quarter and Full Year 2024 Results

February 18, 2025

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

January 29, 2025

ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

January 28, 2025

ICON Issues Financial Guidance for Full Year 2025

January 13, 2025

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

January 7, 2025

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 6, 2025

Calls in 2025

Decks in 2025